Page last updated: 2024-09-05

fosfluconazole and rosiglitazone

fosfluconazole has been researched along with rosiglitazone in 1 studies

Compound Research Comparison

Studies
(fosfluconazole)
Trials
(fosfluconazole)
Recent Studies (post-2010)
(fosfluconazole)
Studies
(rosiglitazone)
Trials
(rosiglitazone)
Recent Studies (post-2010) (rosiglitazone)
23664,7495561,818

Protein Interaction Comparison

ProteinTaxonomyfosfluconazole (IC50)rosiglitazone (IC50)
CDGSH iron-sulfur domain-containing protein 1Rattus norvegicus (Norway rat)1.1
Bile salt export pumpHomo sapiens (human)4.5853
Carbonic anhydrase 2Homo sapiens (human)4.069
Peroxisome proliferator-activated receptor alphaMus musculus (house mouse)0.08
Thromboxane-A synthase Homo sapiens (human)3.56
Amine oxidase [flavin-containing] BHomo sapiens (human)0.832
Peroxisome proliferator-activated receptor gammaHomo sapiens (human)0.2481
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.038
ATP-binding cassette sub-family C member 8Homo sapiens (human)0.048
ATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)0.048
Sodium/bile acid cotransporterHomo sapiens (human)5.1
CDGSH iron-sulfur domain-containing protein 2Homo sapiens (human)2.29
CDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)0.731

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1

Other Studies

1 other study(ies) available for fosfluconazole and rosiglitazone

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008